| 发明名称 |
NOVEL RETIGABINE COMPOSITION |
| 摘要 |
The present invention relates to an oral dosage form comprising N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine) or a pharmaceutically acceptable salt or solvate thereof, to a process for preparing such a dosage form and to the use of such a dosage form in medicine. |
| 申请公布号 |
US2012288544(A1) |
申请公布日期 |
2012.11.15 |
| 申请号 |
US201113574077 |
申请日期 |
2011.01.18 |
| 申请人 |
BURKE MATTHEW;RHODES CHARLES HARDING;GLAXO GROUP LIMITED |
发明人 |
BURKE MATTHEW;RHODES CHARLES HARDING |
| 分类号 |
A61K9/00;A61K31/24 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
